Ayoosh Pareek1, James L Carey2, Patrick J Reardon1, Lars Peterson3, Michael J Stuart1, Aaron J Krych1. 1. Department of Orthopedic Surgery and Sports Medicine, Mayo Clinic, Rochester, MN, USA. 2. Department of Orthopedic Surgery, University of Pennsylvania, Philadelphia, PA, USA. 3. Department of Orthopedic Surgery, University of Gothenburg, Gothenburg, Sweden.
Abstract
OBJECTIVE: Autologous chondrocyte implantation (ACI) has not been proven to be durable over the long-term. The purpose of this systematic review was (1) to evaluate activity level and knee function, (2) to evaluate reoperation and failure rates, and (3) to analyze risk factors for reoperation and failure of ACI at minimum long-term follow-up. DESIGN: A comprehensive review was performed for studies with long-term outcomes after ACI for cartilage defect repair. Studies reported outcome scores such as Tegner score, Lysholm score, and International Knee Documentation Society (IKDC) score along with rates of failure and reoperation. Modified Coleman Methodology Scores were calculated to assess study methodological quality. RESULTS: Nine studies with a total of 771 patients with a mean age of 33.4 ± 2.5 years, mean defect size of 5.9 ± 1.6 cm(2), and mean follow-up of 11.4 years were included. Tegner score, Lysholm score, and IKDC score change from preoperative to final follow-up was 1.1 (95% CI 0.8-1.4, P < 0.001), 24.9 points (95% CI 18.8-31, P < 0.001), and 16.5 points (95% CI 5.4-27.5, P < 0.01), respectively. The mean failure and reoperation rates were 18% and 37%, respectively. Increased age and lesion size (>4.5 cm(2)) were significantly correlated with increased risk of reoperation and failure. CONCLUSIONS: Overall, ACI demonstrated successful outcomes in 82% of patients over the long-term. Increased patient age and lesion size greater than 4.5 cm(2) were risk factors for a higher reoperation and failure rate. Nonetheless, this review is limited by heterogeneity in surgical technique, and lesion and patient characteristics.
OBJECTIVE: Autologous chondrocyte implantation (ACI) has not been proven to be durable over the long-term. The purpose of this systematic review was (1) to evaluate activity level and knee function, (2) to evaluate reoperation and failure rates, and (3) to analyze risk factors for reoperation and failure of ACI at minimum long-term follow-up. DESIGN: A comprehensive review was performed for studies with long-term outcomes after ACI for cartilage defect repair. Studies reported outcome scores such as Tegner score, Lysholm score, and International Knee Documentation Society (IKDC) score along with rates of failure and reoperation. Modified Coleman Methodology Scores were calculated to assess study methodological quality. RESULTS: Nine studies with a total of 771 patients with a mean age of 33.4 ± 2.5 years, mean defect size of 5.9 ± 1.6 cm(2), and mean follow-up of 11.4 years were included. Tegner score, Lysholm score, and IKDC score change from preoperative to final follow-up was 1.1 (95% CI 0.8-1.4, P < 0.001), 24.9 points (95% CI 18.8-31, P < 0.001), and 16.5 points (95% CI 5.4-27.5, P < 0.01), respectively. The mean failure and reoperation rates were 18% and 37%, respectively. Increased age and lesion size (>4.5 cm(2)) were significantly correlated with increased risk of reoperation and failure. CONCLUSIONS: Overall, ACI demonstrated successful outcomes in 82% of patients over the long-term. Increased patient age and lesion size greater than 4.5 cm(2) were risk factors for a higher reoperation and failure rate. Nonetheless, this review is limited by heterogeneity in surgical technique, and lesion and patient characteristics.
Authors: Jan M Pestka; Gerrit Bode; Gian Salzmann; Mathias Steinwachs; Hagen Schmal; Norbert P Südkamp; Philipp Niemeyer Journal: Am J Sports Med Date: 2013-10-28 Impact factor: 6.202
Authors: J Bruce Moseley; Allen F Anderson; Jon E Browne; Bert R Mandelbaum; Lyle J Micheli; Freddie Fu; Christoph Erggelet Journal: Am J Sports Med Date: 2010-02 Impact factor: 6.202
Authors: A Viste; M Piperno; R Desmarchelier; S Grosclaude; B Moyen; M H Fessy Journal: Orthop Traumatol Surg Res Date: 2012-09-29 Impact factor: 2.256
Authors: Ryan P Coughlin; Arnav Gupta; Olawale A Sogbein; Ajaykumar Shanmugaraj; Adrian Z Kurz; Nicole Simunovic; Yi-Meng Yen; Olufemi R Ayeni Journal: Curr Rev Musculoskelet Med Date: 2019-12
Authors: Juan Manuel López-Alcorocho; Isabel Guillén-Vicente; Elena Rodríguez-Iñigo; Marta Guillén-Vicente; Tomás Fernando Fernández-Jaén; Rosa Caballero; Mercedes Casqueiro; Pilar Najarro; Steve Abelow; Pedro Guillén-García Journal: Cartilage Date: 2018-01-11 Impact factor: 4.634
Authors: Jakob Ackermann; Takahiro Ogura; Robert A Duerr; Alexandre Barbieri Mestriner; Andreas H Gomoll Journal: Cartilage Date: 2018-07-04 Impact factor: 4.634
Authors: Juan Manuel Lopez-Alcorocho; Lucia Aboli; Isabel Guillen-Vicente; Elena Rodriguez-Iñigo; Marta Guillen-Vicente; Tomás F Fernández-Jaén; Santiago Arauz; Steve Abelow; Pedro Guillen-García Journal: Cartilage Date: 2017-02-15 Impact factor: 4.634